What's breaking now, across thousands of outlets.
Will the 20th time be the charm?
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
This biotech stock could soar 30% or more over the next 12 months if some analysts are right.
One of the hedge fund industry's longest-running compensation disputes is heading back to court, with former Touradji Capital traders Gentry Beach and Robert Vollero seeking as much as $165m in…
French government bond yields rose, staying at elevated levels amid building concerns over the country’s indebtness.
The Japanese prime minister said the government would pursue fiscal sustainability even as it ramps up spending to bolster growth potential.
